Johns Hopkins Kimmel Cancer Center Podcasts

Dr Akila Viswanathan talks with Dr Robert Timmerman from UT Southwestern about radiation therapy for oligometastatic disease as part of our series for Seminars in Radiation Oncology.

Dr Ashwani Rajput talks with Dr Stephen Broderick and Dr Andrew Lerner about the multidisciplinary approach to lung cancer care at Johns Hopkins in the greater Washington DC area.

Dr Akila Viswanathan speaks with Dr Sahaja Acharya, Director of Pediatric Radiation Oncology, about treating children with brain tumors.

Dr Akila Viswanathan and Dr Aditya Halthore discuss the treatment of patients with lung and genitourinary cancers at the Johns Hopkins Proton Therapy Center located at Sibley Memorial Hospital in Washington DC.

Dr Akila Viswanathan speaks with Dr Philipp Oberdoerffer about his research on how cells function or stop functioning, and how that can result in diseases like cancer.

Dr Akila Viswanathan talks with Dr Wilfred Ngwa about both his work as the Director of the Global Health Catalyst, which aims to reduce cancer health disparities around the world, and his research pairing medical physics with immunotherapy.

Learn more at globalhealthcatalystsummit.org

Dr Bill Nelson speaks with Dr Donald L Trump and Eric Rosenthal about their new book, Centers of the Cancer Universe: A Half-Century of Progress Against Cancer.

For more information or to purchase the book, visit: https://rowman.com/ISBN/9781538144893/Centers-of-the-Cancer-Universe-A-Half-Century-of-Progress-Against-Cancer

Dr Ashwani Rajput talks with Jessica Melton, the new President of Suburban Hospital.

Dr Bill Nelson speaks with Dr Vered Stearns, Dr Wen Shen and patient advocate Kate Pisano about the Johns Hopkins Women's Wellness Program that helps guide women through their cancer treatment, recovery, and care continuum. For more information about the program, email [email protected].

Dr Bill Nelson talks with Dr Janis Taube and Dr Alex Szalay about AstroPath, a new platform that combines astronomy with pathology to identify predictive biomarkers for cancer immunotherapy.